This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Pall Sterile Cord Blood Collection Unit

Read time: 1 mins
Marketing start date: 28 Apr 2024

Summary of product characteristics


Description

ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION (CPD) Sterile, non-pyrogenic fluid path. Sterilized by steam. This product is free of natural rubber latex.

Indications And Usage

Indications and Usage Section For collection of up to 210 ml of umbilical cord blood. Use aseptic technique. Contents inside overwrap pouch, within the foil envelope, are sterile and acceptable for use in a sterile field if pouch is unopened and undamaged; visual inspection to confirm the integrity of overwrap pouch should be performed.

Effective Time

20231220

Version

3

Spl Product Data Elements

Pall Sterile Cord Blood Collection Unit Sterile Cord Blood Collection Unit WATER PHOSPHORIC ACID DEXTROSE MONOHYDRATE ANHYDROUS DEXTROSE SODIUM CITRATE ANHYDROUS CITRIC ACID CITRIC ACID MONOHYDRATE ANHYDROUS CITRIC ACID SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE PHOSPHATE ION

Application Number

BN800222

Brand Name

Pall Sterile Cord Blood Collection Unit

Generic Name

Sterile Cord Blood Collection Unit

Product Ndc

79403-791

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

Printed Pouch Label IFU_FR IFU Case label Bag label

Information For Patients

INFORMATION FOR PATIENTS Visit us at www.pall.com/medical For Pall customer service, call: 1.800.645.6578 DonorCare is a registered trademark of ITL Corporation, Canberra, Australia. Produced under license from ThermoGenesis Corp Ensure DonorCare® Needle Guard (DCNG) is positioned on the tubing between the needle hub and Pinch Clamp. Engage Pinch Clamp. Ensure tethered cap is placed securely on the air vent. Using aseptic technique, insert needle into umbilical vein, disengage Pinch Clamp to collect cord blood, mixing frequently, according to standard procedures. Upon completion of collection, engage Pinch Clamp then withdraw needle from umbilical vein. Slide the DCNG midway over the needle hub. While holding the sides of DCNG near front, grasp tubing and pull smoothly, pulling needle into the DCNG until it locks into place. Confirm that needle is locked by listening for the second click as the needle is drawn into the DCNG. Ensure that tubing cannot be pulled through DCNG. Place the bag on a work surface. While holding the tubing above the bag, open the tethered cap on the air vent. Allow the blood to drain from the tubing into the bag. When the tubing has been drained, hold tubing vertical and seal tubing directly below the Y-piece with air vent. Detach and discard needle, DCNG, Pinch Clamp, Air Vent and tubing according to standard procedures. Determine amount of anticoagulated blood collected. If required, add sedimenting agent to CPD anticoagulated blood through Sample Port using a syringe according to standard procedures. Mix well. Take care to strip and mix any blood in tubing. Load bag into centrifuge cup. It is suggested that a means of support is used to prevent bag from collapsing and to reduce wrinkles. Centrifuge according to standard procedures to obtain mononuclear cell-rich plasma.

How Supplied

HOW SUPPLIED The Collection Unit inside the overwrap pouch, within the foil envelope, are sterile and acceptable for use in a sterile field if pouch is unopened and undamaged.

Precautions

GENERAL PRECAUTIONS Do not use if the package is damaged or seal is incomplete. Use only if solution is clear. Sealing should be done in a manner that avoids fluid splatter. Always dispose of blood-contaminated products in a manner consistent with established BIOHAZARD safety procedures.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.